QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Forecast, Price & News

$1.03
+0.15 (+17.05%)
(As of 06/5/2023 ET)
Compare
Today's Range
$0.88
$1.04
50-Day Range
$0.73
$1.07
52-Week Range
$0.71
$3.55
Volume
10.25 million shs
Average Volume
6.77 million shs
Market Capitalization
$497.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.08

Clover Health Investments MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
102.3% Upside
$2.08 Price Target
Short Interest
Healthy
7.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.63) to ($0.39) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Medical Sector

824th out of 986 stocks

Hospital & Medical Service Plans Industry

11th out of 11 stocks


CLOV stock logo

About Clover Health Investments (NASDAQ:CLOV) Stock

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

CLOV Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
What's Going On With Clover Health Stock Wednesday?
Clover Health Investments improves 2023 guidance
See More Headlines

CLOV Price History

CLOV Company Calendar

Today
6/05/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
680
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.08
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+104.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-338,840,000.00
Pretax Margin
-10.73%

Debt

Sales & Book Value

Annual Sales
$3.48 billion
Book Value
$0.73 per share

Miscellaneous

Free Float
379,270,000
Market Cap
$492.30 million
Optionable
Not Optionable
Beta
1.97

Key Executives

  • Mr. Vivek GaripalliMr. Vivek Garipalli (Age 44)
    Co-Founder & Chairman Of Board
  • Mr. Andrew Toy (Age 43)
    Co-Founder, CEO & Director
    Comp: $537.89k
  • Ms. Jamie L. Reynoso (Age 53)
    Chief Operating Officer
    Comp: $461.74k
  • Mr. Prabhdeep Singh (Age 38)
    Chief Growth Officer
    Comp: $399.14k
  • Mr. Scott J. Leffler (Age 48)
    Chief Financial Officer
  • Mr. Conrad Wai
    Chief Technology Officer
  • Mr. Derrick L. Nueman
    Head of Investor Relations & Corp. strategy
  • Ms. Wendy Richey
    Chief Compliance Officer
  • Mr. Joseph Richards Martin (Age 46)
    Gen. Counsel & Corp. Sec.
  • Ms. Rachel Fish
    Chief People Officer













CLOV Stock - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings
or view top-rated stocks.

What is Clover Health Investments' stock price forecast for 2023?

4 analysts have issued twelve-month price targets for Clover Health Investments' stock. Their CLOV share price forecasts range from $1.00 to $4.00. On average, they expect the company's share price to reach $2.08 in the next twelve months. This suggests a possible upside of 104.2% from the stock's current price.
View analysts price targets for CLOV
or view top-rated stocks among Wall Street analysts.

How have CLOV shares performed in 2023?

Clover Health Investments' stock was trading at $0.9295 at the start of the year. Since then, CLOV shares have increased by 9.7% and is now trading at $1.02.
View the best growth stocks for 2023 here
.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 37,550,000 shares, a drop of 5.7% from the April 30th total of 39,820,000 shares. Based on an average daily volume of 6,700,000 shares, the days-to-cover ratio is currently 5.6 days.
View Clover Health Investments' Short Interest
.

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our CLOV earnings forecast
.

What ETFs hold Clover Health Investments' stock?
What guidance has Clover Health Investments issued on next quarter's earnings?

Clover Health Investments updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.93 billion-$2.03 billion, compared to the consensus revenue estimate of $1.95 billion.

What is Clover Health Investments' stock symbol?

Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.55%), State Street Corp (1.84%), Geode Capital Management LLC (1.44%), Renaissance Technologies LLC (1.43%), Charles Schwab Investment Management Inc. (0.50%) and Susquehanna International Group LLP (0.00%). Insiders that own company stock include Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends
.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clover Health Investments' stock price today?

One share of CLOV stock can currently be purchased for approximately $1.02.

How much money does Clover Health Investments make?

Clover Health Investments (NASDAQ:CLOV) has a market capitalization of $492.30 million and generates $3.48 billion in revenue each year. The company earns $-338,840,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis.

How many employees does Clover Health Investments have?

The company employs 680 workers across the globe.

How can I contact Clover Health Investments?

Clover Health Investments' mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The official website for the company is www.cloverhealth.com. The company can be reached via phone at 201-432-2133 or via email at investors@cloverhealth.com.

This page (NASDAQ:CLOV) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -